For instance, COBLL1, a gene with liver-specific colocalization for fasting insulin and BMI and previously associated with non-alcoholic fatty liver disease [12, 60], showed decreased expression under both atorvastatin and metformin in the liver. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.